Data as of Nov 25
| +0.27 / +0.28%|
The 27 analysts offering 12-month price forecasts for Novartis have a median target of 97.64, with a high estimate of 109.00 and a low estimate of 79.53. The median estimate represents a +2.74% increase from the last price of 95.04.
The current consensus among 30 polled investment analysts is to Buy stock in Novartis. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.